Published in Gene Therapy Weekly, April 19th, 1999
A.K. Stewart and colleagues from several institutions in Canada and the United States conducted a phase 1 trial of direct injection of an E1,E3-deleted adenovirus encoding IL-2 (AdCAIL-2) into subcutaneous deposits of melanoma or breast cancer ("Adenovector-Mediated Gene Delivery of Interleukin-2 in Metastatic Breast Cancer and Melanoma: Results of a Phase 1 Clinical Trial," Gene Therapy, March 1999;6(3):350-63).
"To begin to explore the utility and safety of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.